Overall rank by patents
#1,307
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Express Scripts Strategic Development, Inc.
USPTO PatentsView assignee record — 324 granted patents across 55 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).
324
Total patents granted
55
CPC technology areas
17.9
Avg claims per patent
+536%
5-year filing velocity
Portfolio overview
Express Scripts Strategic Development, Inc. has been granted 324 US utility patents between 2017 and 2025, placing Express Scripts Strategic Development, Inc. at rank #1,307 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, Express Scripts Strategic Development, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 68.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 280 grants, compared with 44 in the 2015–2019 window — a +536% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Express Scripts Strategic Development, Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Express Scripts Strategic Development, Inc. against peers pursuing similar technology classes.
How does Express compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Express Scripts S… ◀ 324
Express Scripts Strategic Development, Inc.
324 patents
What this shows Express holds 324 patents — placing it at rank #1,307 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2017–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 0.3% |
| 2018 | 19 | 5.9% |
| 2019 | 24 | 7.4% |
| 2020 | 39 | 12.0% |
| 2021 | 32 | 9.9% |
| 2022 | 63 | 19.4% |
| 2023 | 68 | 21.0% |
| 2024 | 49 | 15.1% |
| 2025 | 29 | 9.0% |
Which technologies does Express Scripts Strategic Development, Inc. patent most?
Top 15 of 55 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does Express Scripts Strategic Development, Inc. hold?
Express Scripts Strategic Development, Inc. holds 324 US granted patents filed between 2017 and 2025, spanning 55 technology areas.
What is Express Scripts Strategic Development, Inc.'s Innovation Score?
Express Scripts Strategic Development, Inc. has an Innovation Score of 68.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Express Scripts Strategic Development, Inc. focus on?
Express Scripts Strategic Development, Inc.'s top technology area is G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA) with 157 patents. The company has filed patents in 55 CPC subclasses total.
Is Express Scripts Strategic Development, Inc.'s patent filing rate increasing or decreasing?
Express Scripts Strategic Development, Inc.'s recent filing velocity is +536% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Express Scripts Strategic Development, Inc.'s patents?
Express Scripts Strategic Development, Inc.'s patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Express Scripts Strategic Development, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
G16H technology
Express Scripts Strategic Development, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Express Scripts Strategic Development, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
